Delivery Order SPE2DB24D9246-SPE2DB25FGUSR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $20,830.80 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order represents no set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under the company's larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,776.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of Mirena 52 mg systems to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of June 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the contractor's location in Park Ridge, Illinois. This delivery order is issued under DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,960.00, is for the delivery of Mirena 52 MG Systems to support the recurring medical supply needs of military health facilities. This Delivery Order is issued under a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued up to...
- The Defense Logistics Agency (DLA) awarded a $5,603.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,238.40 contract is to provide Mirena 52 mg systems to the DLA. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a wide range...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group, a woman-owned small business based in Park Ridge, Illinois, will perform the work at its primary location. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 3, 2025, and was awarded on September 12, 2025. No set-aside designation was applied to this...
- SPE2DB24D9246Indefinite Delivery Contract
- SPE2DB24D9246-SPE2DB25FGUSRDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is set for ultimate completion by August 12, 2025, and represents a discrete purchase under the company's existing relationship with the DLA. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026. The broader SPE2DB program IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. As a consistently successful vendor in federal pharmaceutical procurement, DMS Pharmaceutical Group maintains a robust portfolio of contract awards with the DLA, positioning the company as a critical supplier within the federal defense pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/22/25 |